Home
>
National Drug Code (NDC)
>
Felbamate
Felbamate - 65162-735-03 - (Felbamate)
Drug Information of Felbamate
| Product NDC: | 65162-735 |
| Proprietary Name: | Felbamate |
| Non Proprietary Name: | Felbamate |
| Active Ingredient(s): | 600 mg/1 & nbsp; Felbamate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Felbamate
| Product NDC: | 65162-735 |
| Labeler Name: | Amneal Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA201680 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110916 |
Package Information of Felbamate
| Package NDC: | 65162-735-03 |
| Package Description: | 30 TABLET in 1 BOTTLE (65162-735-03) |
NDC Information of Felbamate
| NDC Code | 65162-735-03 |
| Proprietary Name | Felbamate |
| Package Description | 30 TABLET in 1 BOTTLE (65162-735-03) |
| Product NDC | 65162-735 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Felbamate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110916 |
| Marketing Category Name | ANDA |
| Labeler Name | Amneal Pharmaceuticals |
| Substance Name | FELBAMATE |
| Strength Number | 600 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
